Ark says cancer therapy potent, cuts side-effects
Key points
- Britain's Ark Therapeutics Plc said on Monday its cancer treatment had been found to be highly effective in stopping tumour development using only one tenth of the usual chemotherapy dose.
- The biotechnology company said thanks to its DNA-based drug-targeting technology Scavidin treatments such as radiation or chemotherapy could be given in lower doses to reduce side-effects.
- "These results indicate that Scavidin has the potential both to improve the therapeutic effect and to reduce the unpleasant side-effects of a wide variety of drugs," Chief Executive Nigel Parker said in a statement.
- The biotechnology has "enormous potential" across many disease areas, the group added.
Britain's Ark Therapeutics Plc said on Monday its cancer treatment had been found to be highly effective in stopping tumour development using only one tenth of the usual chemotherapy dose.
The biotechnology company said thanks to its DNA-based drug-targeting technology Scavidin treatments such as radiation or chemotherapy could be given in lower doses to reduce side-effects.
"These results indicate that Scavidin has the potential both to improve the therapeutic effect and to reduce the unpleasant side-effects of a wide variety of drugs," Chief Executive Nigel Parker said in a statement.
The biotechnology has "enormous potential" across many disease areas, the group added.
Shares in Ark Therapeutics closed at 93-1/2 pence on Friday, valuing the group at about 119 million pounds ($207 million).
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMayo researchers decode molecular action of combination therapy for deadly thyroid cancer
In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created…
24 July 2015
NewsNew 'chemotherapy booster' could treat lung and pancreatic cancer
A new drug that blocks cancer's escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports. Scientists have shown in human cancer cells and in mice that the drug -…
24 July 2015
NewsResveratrol, quercetin could provide new options for cancer therapy
Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and…
